메뉴 건너뛰기




Volumn 66, Issue 3, 2007, Pages 206-211

Laboratory diagnostics for systemic sclerosis;Labordiagnostik bei systemischer sklerose

Author keywords

Autoantibodies; Laboratory diagnostics; Scleroderma; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY;

EID: 34250182352     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-007-0156-6     Document Type: Review
Times cited : (1)

References (31)
  • 1
    • 0034203531 scopus 로고    scopus 로고
    • Clinical, serological and genetic study in patients with CREST syndrome
    • Akiyama Y, Tanaka M, Takeishi M et al. (2000) Clinical, serological and genetic study in patients with CREST syndrome. Intern Med 39: 451-456
    • (2000) Intern Med , vol.39 , pp. 451-456
    • Akiyama, Y.1    Tanaka, M.2    Takeishi, M.3
  • 2
    • 12244264813 scopus 로고    scopus 로고
    • Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis
    • Allanore Y, Borderie D, Lemarechal H et al. (2003) Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis. J Rheumatol 30: 68-73
    • (2003) J Rheumatol , vol.30 , pp. 68-73
    • Allanore, Y.1    Borderie, D.2    Lemarechal, H.3
  • 3
    • 33745930239 scopus 로고    scopus 로고
    • Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: Results of a prospective study of sicca syndrome in 133 consecutive patients
    • Avouac J, Sordet C, Depinay C et al. (2006) Systemic sclerosis-associated Sjogren's syndrome and relationship to the limited cutaneous subtype: Results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 54: 2243-2249
    • (2006) Arthritis Rheum , vol.54 , pp. 2243-2249
    • Avouac, J.1    Sordet, C.2    Depinay, C.3
  • 4
    • 33745277147 scopus 로고    scopus 로고
    • Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis
    • Baroni SS, Santillo M, Bevilacqua F et al. (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 354: 2667-2676
    • (2006) N Engl J Med , vol.354 , pp. 2667-2676
    • Baroni, S.S.1    Santillo, M.2    Bevilacqua, F.3
  • 5
    • 0029758449 scopus 로고    scopus 로고
    • Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung
    • Behr J, Vogelmeier C, Beinert T et al. (1996) Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med 154: 400-406
    • (1996) Am J Respir Crit Care Med , vol.154 , pp. 400-406
    • Behr, J.1    Vogelmeier, C.2    Beinert, T.3
  • 6
    • 0024590005 scopus 로고
    • Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: Relationship to disease activity and duration
    • Black CM, McWhirter A, Harrison NK et al. (1989) Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease activity and duration. Br J Rheumatol 28: 98-103
    • (1989) Br J Rheumatol , vol.28 , pp. 98-103
    • Black, C.M.1    McWhirter, A.2    Harrison, N.K.3
  • 7
    • 0028520783 scopus 로고
    • Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro
    • Cambrey AD, Harrison NK, Dawes KE et al. (1994) Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol 11: 439-445
    • (1994) Am J Respir Cell Mol Biol , vol.11 , pp. 439-445
    • Cambrey, A.D.1    Harrison, N.K.2    Dawes, K.E.3
  • 8
    • 2342459078 scopus 로고    scopus 로고
    • Serological assessment of type I collagen burden in scleroderma spectrum disorders: A systematic review
    • Dziadzio M, Smith RE, Abraham DJ et al. (2004) Serological assessment of type I collagen burden in scleroderma spectrum disorders: a systematic review. Clin Exp Rheumatol 22: 356-367
    • (2004) Clin Exp Rheumatol , vol.22 , pp. 356-367
    • Dziadzio, M.1    Smith, R.E.2    Abraham, D.J.3
  • 9
    • 24944515520 scopus 로고    scopus 로고
    • N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma
    • Dziadzio M, Usinger W, Leask A et al. (2005) N-terminal connective tissue growth factor is a marker of the fibrotic phenotype in scleroderma. Q J Med 98: 485-492
    • (2005) Q J Med , vol.98 , pp. 485-492
    • Dziadzio, M.1    Usinger, W.2    Leask, A.3
  • 10
    • 0036124419 scopus 로고    scopus 로고
    • Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients
    • Ferri C, Valentini G, Cozzi F et al. (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81: 139-153
    • (2002) Medicine (Baltimore) , vol.81 , pp. 139-153
    • Ferri, C.1    Valentini, G.2    Cozzi, F.3
  • 11
    • 33646476400 scopus 로고    scopus 로고
    • Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
    • Fijalkowska A, Kurzyna M, Torbicki A et al. (2006) Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 129: 1313-1321
    • (2006) Chest , vol.129 , pp. 1313-1321
    • Fijalkowska, A.1    Kurzyna, M.2    Torbicki, A.3
  • 12
    • 0023903515 scopus 로고
    • Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen
    • Fregeau DR, Leung PS, Coppel RL et al. (1988) Autoantibodies to mitochondria in systemic sclerosis. Frequency and characterization using recombinant cloned autoantigen. Arthritis Rheum 31: 386-392
    • (1988) Arthritis Rheum , vol.31 , pp. 386-392
    • Fregeau, D.R.1    Leung, P.S.2    Coppel, R.L.3
  • 13
    • 33746436186 scopus 로고    scopus 로고
    • Systemische Sklerose - Diagnose und Klassifikation
    • Genth E, Krieg T (2006) Systemische Sklerose - Diagnose und Klassifikation. Z Rheumatol 65: 268
    • (2006) Z Rheumatol , vol.65 , pp. 268
    • Genth, E.1    Krieg, T.2
  • 14
    • 0032058897 scopus 로고    scopus 로고
    • Koinzidenz von Sklerodermie und primär biliärer Zirrhose. Ergebnisse einer systematischen Studie im dermatologischen Krankengut
    • Göring HD, Panzner M, Lakotta W, Ziemer A (1998) Koinzidenz von Sklerodermie und primär biliärer Zirrhose. Ergebnisse einer systematischen Studie im dermatologischen Krankengut. Hautarzt 49: 361-366
    • (1998) Hautarzt , vol.49 , pp. 361-366
    • Göring, H.D.1    Panzner, M.2    Lakotta, W.3    Ziemer, A.4
  • 15
    • 0021188391 scopus 로고
    • Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis
    • Gupta RC, Seibold JR, Krishnan MR, Steigerwald JC (1984) Precipitating autoantibodies to mitochondrial proteins in progressive systemic sclerosis. Clin Exp Immunol 58: 68-76
    • (1984) Clin Exp Immunol , vol.58 , pp. 68-76
    • Gupta, R.C.1    Seibold, J.R.2    Krishnan, M.R.3    Steigerwald, J.C.4
  • 16
    • 0031056613 scopus 로고    scopus 로고
    • Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
    • Hasegawa M, Fujimoto M, Kikuchi K, Takehara K (1997) Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 24: 328-332
    • (1997) J Rheumatol , vol.24 , pp. 328-332
    • Hasegawa, M.1    Fujimoto, M.2    Kikuchi, K.3    Takehara, K.4
  • 17
    • 0346727461 scopus 로고    scopus 로고
    • Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis
    • Jimenez SA, Derk CT (2004) Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 140: 37-50
    • (2004) Ann Intern Med , vol.140 , pp. 37-50
    • Jimenez, S.A.1    Derk, C.T.2
  • 18
    • 17544370003 scopus 로고    scopus 로고
    • Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: Relationship to organ systemic involvement
    • Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S (2005) Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol 24: 111-116
    • (2005) Clin Rheumatol , vol.24 , pp. 111-116
    • Kuryliszyn-Moskal, A.1    Klimiuk, P.A.2    Sierakowski, S.3
  • 19
    • 31844452583 scopus 로고    scopus 로고
    • Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature
    • Mendoza FA, Artlett CM, Sandorfi N et al. (2006) Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35: 238-249
    • (2006) Semin Arthritis Rheum , vol.35 , pp. 238-249
    • Mendoza, F.A.1    Artlett, C.M.2    Sandorfi, N.3
  • 20
    • 33746447826 scopus 로고    scopus 로고
    • Sklerodermie-assoziierte Autoantikörper - klinische und diagnostische Relevanz
    • Mierau R, Genth E (2006) Sklerodermie-assoziierte Autoantikörper - klinische und diagnostische Relevanz. Z Rheumatol 65: 279-284
    • (2006) Z Rheumatol , vol.65 , pp. 279-284
    • Mierau, R.1    Genth, E.2
  • 21
    • 33845600333 scopus 로고    scopus 로고
    • A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16
    • Mondini M, Vidali M, Andrea MD et al. (2006) A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16. Arthritis Rheum 54: 3939-3944
    • (2006) Arthritis Rheum , vol.54 , pp. 3939-3944
    • Mondini, M.1    Vidali, M.2    Andrea, M.D.3
  • 22
    • 32144452902 scopus 로고    scopus 로고
    • Racial variation in clinical and immunological manifestations of systemic sclerosis
    • Nietert PJ, Mitchell HC, Bolster MB et al. (2006) Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 33: 263-268
    • (2006) J Rheumatol , vol.33 , pp. 263-268
    • Nietert, P.J.1    Mitchell, H.C.2    Bolster, M.B.3
  • 23
    • 0028986064 scopus 로고
    • Circulating interleukin 1 beta and soluble interleukin 2 receptor: Evaluation as markers of disease activity in scleroderma
    • Patrick MR, Kirkham BW, Graham M, Harrision LC (1995) Circulating interleukin 1 beta and soluble interleukin 2 receptor: evaluation as markers of disease activity in scleroderma. J Rheumatol 22: 654-658
    • (1995) J Rheumatol , vol.22 , pp. 654-658
    • Patrick, M.R.1    Kirkham, B.W.2    Graham, M.3    Harrision, L.C.4
  • 24
    • 33646466924 scopus 로고    scopus 로고
    • Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis
    • Peterlana D, Puccetti A, Caramaschi P et al. (2006) Endothelin-1 serum levels correlate with MCP-1 but not with homocysteine plasma concentration in patients with systemic sclerosis. Scand J Rheumatol 35: 133-137
    • (2006) Scand J Rheumatol , vol.35 , pp. 133-137
    • Peterlana, D.1    Puccetti, A.2    Caramaschi, P.3
  • 25
    • 33144461273 scopus 로고    scopus 로고
    • Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis
    • Rigamonti C, Shand LM, Feudjo M et al. (2006) Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55: 388-394
    • (2006) Gut , vol.55 , pp. 388-394
    • Rigamonti, C.1    Shand, L.M.2    Feudjo, M.3
  • 26
    • 0035171979 scopus 로고    scopus 로고
    • Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension
    • Rubens C, Ewert R, Halank M et al. (2001) Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension. Chest 120: 1562-1569
    • (2001) Chest , vol.120 , pp. 1562-1569
    • Rubens, C.1    Ewert, R.2    Halank, M.3
  • 27
    • 0033785184 scopus 로고    scopus 로고
    • Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement
    • Scheja A, Wildt M, Wollheim FA et al. (2000) Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology (Oxford) 39: 1110-1113
    • (2000) Rheumatology (Oxford) , vol.39 , pp. 1110-1113
    • Scheja, A.1    Wildt, M.2    Wollheim, F.A.3
  • 28
    • 17844378013 scopus 로고    scopus 로고
    • Frühdiagnostik von chronischen Nierenerkrankungen
    • Schulze-Lohoff E, Matthaus T, Weber M (2005) Frühdiagnostik von chronischen Nierenerkrankungen. Internist 46: 378-388
    • (2005) Internist , vol.46 , pp. 378-388
    • Schulze-Lohoff, E.1    Matthaus, T.2    Weber, M.3
  • 29
    • 0036118293 scopus 로고    scopus 로고
    • Predicting mortality in systemic sclerosis: Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival
    • Scussel-Lonzetti L, Joyal F, Raynauld JP et al. (2002) Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine 81: 154-167
    • (2002) Medicine , vol.81 , pp. 154-167
    • Scussel-Lonzetti, L.1    Joyal, F.2    Raynauld, J.P.3
  • 30
    • 0028029736 scopus 로고
    • Circulating endothelin-1 levels in systemic sclerosis subsets-a marker of fibrosis or vascular dysfunction?
    • Vancheeswaran R, Magoulas T, Efrat G et al. (1994) Circulating endothelin-1 levels in systemic sclerosis subsets-a marker of fibrosis or vascular dysfunction? J Rheumatol 21: 1838-1844
    • (1994) J Rheumatol , vol.21 , pp. 1838-1844
    • Vancheeswaran, R.1    Magoulas, T.2    Efrat, G.3
  • 31
    • 33745725935 scopus 로고    scopus 로고
    • Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
    • Williams MH, Handler CE, Akram R et al. (2006) Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J 27: 1485-1494
    • (2006) Eur Heart J , vol.27 , pp. 1485-1494
    • Williams, M.H.1    Handler, C.E.2    Akram, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.